Thrombin Decreases the Urokinase Receptor and Surface-Localized Fibrinolysis in Cultured Endothelial Cells
- 1 March 1995
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (3) , 410-419
- https://doi.org/10.1161/01.atv.15.3.410
Abstract
The endothelial cell (EC) urokinase receptor plays an important role in the localization and receptor-mediated activation of EC-bound plasminogen and hence surface-localized fibrinolysis. Thrombin induced a rapid (125I-labeled two-chain urokinase-type plasminogen activator (tcu-PA) or diisopropylfluorophosphate–tcu-PA to urokinase-type plasminogen activator receptor (u-PAR) in cultured ECs from various sources (range, 21% to 50%). The thrombin receptor activation peptide but not control peptide showed a similar but reduced decrease in the specific binding of125I-labeled tcu-PA to u-PAR. Incubation of thrombin-treated cultures (10 to 12 hours) in complete medium restored125I-labeled tcu-PA ligand binding to normal levels. u-PAR mRNA levels rapidly (1 hour) increased and peaked 10 to 12 hours after thrombin treatment as analyzed by reverse transcriptase–polymerase chain reaction. Decreased thrombin-induced125I-labeled tcu-PA binding correlated with the time-dependent decrease in surface-localized plasmin generation, as measured by the direct activation of125I-labeled Glu-plasminogen and quantification of the 20-kD light chains of125I-labeled plasmin. After incubation with thrombin, plasmin generation was decreased 50% to 56% (125 to 152 fmol/3 to 3.5×104cells). Isolation of metabolically labeled35S-labeled u-PAR from the media of thrombin and phospholipase C–treated human aortic cultures yielded ≈10- and ≈12-fold more 55-kDMrand ≈6-fold more 35-kDMr35S-labeled u-PAR forms than control cultures, respectively. The u-PAR antigen forms (Mr, 54 kD) and the glycosyl-phosphatidylinositol–anchored protein CD59 (Mr, 20 kD) were also simultaneously identified by immunoprecipitation in the media of thrombin-treated cultures. This suggests that thrombin may release u-PAR and decrease u-PA ligand binding through a common pathway involving phospholipase C. These results establish a novel interrelation between thrombin and EC fibrinolysis and suggest that thrombin may also have an additional regulatory role in the net expression of surface-localized EC fibrinolytic activity.Keywords
This publication has 36 references indexed in Scilit:
- Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.Journal of Clinical Investigation, 1993
- Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.The Journal of cell biology, 1991
- Thrombin and histamine activate phospholipase C in human endothelial cells via a phorbol ester‐sensitive pathwayJournal of Cellular Physiology, 1988
- Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.Journal of Clinical Investigation, 1986
- Urokinase‐type and tissue‐type plasminogen activators have different distributions in cultured bovine capillary endothelial cellsJournal of Cellular Biochemistry, 1986
- Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein.The Journal of cell biology, 1984
- Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells.Journal of Clinical Investigation, 1984
- Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial CultivationScience, 1983
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970